[go: up one dir, main page]

HUP0200825A2 - Compositions and methods for the treatment and diagnosis of breast cancer - Google Patents

Compositions and methods for the treatment and diagnosis of breast cancer

Info

Publication number
HUP0200825A2
HUP0200825A2 HU0200825A HUP0200825A HUP0200825A2 HU P0200825 A2 HUP0200825 A2 HU P0200825A2 HU 0200825 A HU0200825 A HU 0200825A HU P0200825 A HUP0200825 A HU P0200825A HU P0200825 A2 HUP0200825 A2 HU P0200825A2
Authority
HU
Hungary
Prior art keywords
diagnosis
compositions
treatment
methods
breast cancer
Prior art date
Application number
HU0200825A
Other languages
English (en)
Inventor
Davin C Dillon
Tony N Frudakis
Lynda E Misher
Steven G Reed
Marc W Retter
John M Smith
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of HUP0200825A2 publication Critical patent/HUP0200825A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0200825A 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer HUP0200825A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
HUP0200825A2 true HUP0200825A2 (en) 2002-07-29

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200825A HUP0200825A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Country Status (15)

Country Link
EP (1) EP1169444A2 (hu)
JP (1) JP2002541803A (hu)
KR (1) KR20020026418A (hu)
CN (1) CN1352683A (hu)
AU (1) AU774824B2 (hu)
BR (1) BR0009573A (hu)
CA (1) CA2365909A1 (hu)
CZ (1) CZ20013575A3 (hu)
HU (1) HUP0200825A2 (hu)
IL (1) IL145719A0 (hu)
MX (1) MXPA01010186A (hu)
NO (1) NO20014805L (hu)
NZ (1) NZ514646A (hu)
PL (1) PL350863A1 (hu)
WO (1) WO2000061753A2 (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025431A1 (en) * 1996-01-10 1997-07-17 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
WO1997025426A2 (en) * 1996-01-11 1997-07-17 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
WO2000004149A2 (en) * 1998-07-14 2000-01-27 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
JP2002508182A (ja) * 1997-12-17 2002-03-19 ジェンセット 分泌タンパク質の伸長ｃＤＮＡ

Also Published As

Publication number Publication date
IL145719A0 (en) 2002-07-25
CN1352683A (zh) 2002-06-05
NO20014805L (no) 2001-12-06
AU774824B2 (en) 2004-07-08
MXPA01010186A (es) 2004-08-12
PL350863A1 (en) 2003-02-10
AU4213000A (en) 2000-11-14
WO2000061753A2 (en) 2000-10-19
CA2365909A1 (en) 2000-10-19
EP1169444A2 (en) 2002-01-09
NO20014805D0 (no) 2001-10-03
NZ514646A (en) 2005-04-29
CZ20013575A3 (cs) 2002-10-16
KR20020026418A (ko) 2002-04-10
BR0009573A (pt) 2002-04-16
WO2000061753A3 (en) 2001-06-28
JP2002541803A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
PT1716853E (pt) Utiliza??o de et743 para o tratamento de cancro em seres humanos
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
HUP0104963A3 (en) Compositions for the treatment of skin diseases
PL350890A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
HUP0200825A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL141426A0 (en) Compositions and methods for the treatment of tumor